PICK A TIME SLOT
₹ Price not available
₹
You will receive an SMS with a verification code on this number.
Are you new to hospital ?
We have sent you an OTP on
Resend OTP
Did not receive OTP? You can request for another OTP. Click on Resend OTP
Go Back
Your appointment is
confirmed.
The details will be shared via Email & SMS
Note :Temporary visitor restriction, only one attendant is permitted with the patient. Your cooperation is solicited.
-
-
-
-
-
-
Listen to doctor overview
Loading audio...
Dr. Rahul Roy Chowdhury is a distinguished consultant in the Obstetrics and Gynaecology Department at Manipal Hospitals in Dhakuria, Kolkata, with 33 years of extensive experience, including 19 years as a specialist. He completed his Bachelor of Medicine and Bachelor of Surgery (MBBS) from the esteemed University of Calcutta, India. He then earned a fellowship from the Royal College of Obstetricians and Gynaecologists (FRCOG) in London. Additionally, he holds a Completion Certificate of Training from the Professional Medical Educational and Training Board in the UK. He is the Best Gynecologist Oncologist in Kolkata.
Dr. Chowdhury is widely renowned for his exceptional expertise in performing Pelvic and Upper Abdominal Surgeries, Peritonectomies, and Laparoscopic Procedures tailored specifically for managing endometrial cancers. His specialisation in Gynaecological Oncology occurred at the renowned Oxford Cancer Centre within The John Radcliffe Hospital from 2003 to 2007. Dr. Chowdhury continued to refine his expertise in Gynaecological Oncology across various esteemed institutions. He established himself as a prominent expert in the field upon returning to India in 2008.
Dr. Chowdhury is actively engaged in pioneering clinical research endeavours, contributing significantly to practice-changing trials such as INTERLACE (Induction Chemotherapy in locally advanced cervical cancer). His unwavering dedication to advancing the field of Gynaecological Oncology underscores his commitment to improving patient outcomes and enhancing medical knowledge. Dr. Chowdhury is also associated with esteemed societies, including the Association of Gynaecologic Oncologists of India (AGOI), the Indian Society of Colonoscopy and Cervical Pathology (ISCCP), the Royal College of Obstetrics and Gynaecologists (MRCOG), and the Kolkata Gyneoncology Trials and Translational Research Group (KolGO Trg). Moreover, Dr. Chowdhury has published several papers in various national and international journals and has presented topics in many distinguished conferences. His proficiency in the languages of English, Hindi, and Bengali enables him to communicate effectively, empowering patients to share their concerns.
- Expertise in performing Gynaecologic Oncological Surgeries, such as Pelvic and Upper Abdominal Surgeries, Peritonectomies, and Radical Pelvic Floor Clearances in ovarian and cervical cancers, improving the lives of these patients.
- Skilled in Minimally Invasive Laparoscopic Procedures such as Laparoscopic Pelvic and Retroperitoneal Nodal Clearances for the treatment of endometrial cancers.
- Experienced in performing Vulvar Cancer surgeries and providing specialised care for patients.
- Fellow of the Royal College of Obstetricians and Gynaecologists, UK (FRCOG)
- Member of the Royal College of Obstetricians and Gynaecologists, UK (MRCOG)
- Member of the Association of Gynaecologic Oncology
- Member of the Gynae Cancer InterGroup
- Founding member of the Kolkata Gynecological Oncology Trials and Translational Research Group
- English
- Bengali
- Hindi
- Local Mentor for In-Country IGCS Fellowship, India
- LMIC representative for the 1st Endometrial Cancer Consensus Conference for Clinical Research (ECCC-CR) on November 2nd and 3rd, 2023, in Seoul, Korea
- Resource person for training consultants at Chittagong Medical College, Chittagong, Bangladesh [Invited by Medical Education and Health Manpower Development, Directorate General of Medical Education, Dhaka]
- Ghosh DD, Chowdhury R R, Dutta R, Mukhopadhyay I, Mukhopadhyay A, Roychoudhury S. In-silico analysis of TCGA data showing multiple POLE-like favourable subgroups overlapping with TP53 mutated endometrial cancer: Implications for clinical practice in low and middle-income countries. https://doi.org/10.1016/j.gore.2023.101209
- Mandal P, Bhattacharjee B, Sen S, Bhattacharya A, Saha SS, Chowdhury RR, Mondal NR, Chakrabarty B, Chatterjee T, Roy S, Sengupta S. Predominance of genomically defined A lineage of HPV16 over D lineage in Indian patients from eastern India with squamous cell carcinoma of the cervix in association with distinct oncogenic phenotypes. Transl Oncol. 2021 Oct 27;15(1):101256. doi: 10.1016/j.tranon.2021.101256. Epub ahead of print. PMID: 34717279; PMCID: PMC8564679.
- Kurtz JE, Gebski V, Sukhin V, Carey M, Kong I, Glasspool RM, Berek JS, de Paiva Batista M, Hall M, Kim JW, Yeoshoua E, Fujiwara N, Nam BH, Polleis S, Lee JY, Strojna A, Farrelly L, Schwameis R, Fossati R, Darlington AS, Lai CH, Wright AA, Rosenblat O, Harter P, Roxburgh P, Chowdhury RR, Chang TC, Paoletti X, Friedlander M; Gynecologic Cancer InterGroup (GCIG) symptom benefit committee. Incorporating patient centered benefits as endpoints in randomized trials of maintenance therapies in advanced ovarian cancer: A position paper from the GCIG symptom benefit committee. Gynecol Oncol. 2021 May;161(2):502-507. doi: 10.1016/j.ygyno.2021.02.018. Epub 2021 Feb 19. PMID: 33612336.
- Poster presentation
- Mukhopadhyay A, Ghosh T, Bhattacharjee D, Chakraborty D, Gupta , Roychowdhury I, Chatterjee P, Vemekar M, Chowdhury RR, Intermittent PARP Inhibitor Regimen In Ovarian Cancer (IPIROC): Origin and Feasibility Of Implementing A Proof –Of –Concept Exploratory Study.18 October 2023 IGCS Abstracts.
Overview
Field of Expertise
Fellowship & Membership
Languages Spoken
Awards & Achievements
Talks & Publications
- Fellow of the Royal College of Obstetricians and Gynaecologists, UK (FRCOG)
- Member of the Royal College of Obstetricians and Gynaecologists, UK (MRCOG)
- Member of the Association of Gynaecologic Oncology
- Member of the Gynae Cancer InterGroup
- Founding member of the Kolkata Gynecological Oncology Trials and Translational Research Group
Dr. Rahul Roy Chowdhury is a distinguished consultant in the Obstetrics and Gynaecology Department at Manipal Hospitals in Dhakuria, Kolkata, with 33 years of extensive experience, including 19 years as a specialist. He completed his Bachelor of Medicine and Bachelor of Surgery (MBBS) from the esteemed University of Calcutta, India. He then earned a fellowship from the Royal College of Obstetricians and Gynaecologists (FRCOG) in London. Additionally, he holds a Completion Certificate of Training from the Professional Medical Educational and Training Board in the UK. He is the Best Gynecologist Oncologist in Kolkata.
Dr. Chowdhury is widely renowned for his exceptional expertise in performing Pelvic and Upper Abdominal Surgeries, Peritonectomies, and Laparoscopic Procedures tailored specifically for managing endometrial cancers. His specialisation in Gynaecological Oncology occurred at the renowned Oxford Cancer Centre within The John Radcliffe Hospital from 2003 to 2007. Dr. Chowdhury continued to refine his expertise in Gynaecological Oncology across various esteemed institutions. He established himself as a prominent expert in the field upon returning to India in 2008.
Dr. Chowdhury is actively engaged in pioneering clinical research endeavours, contributing significantly to practice-changing trials such as INTERLACE (Induction Chemotherapy in locally advanced cervical cancer). His unwavering dedication to advancing the field of Gynaecological Oncology underscores his commitment to improving patient outcomes and enhancing medical knowledge. Dr. Chowdhury is also associated with esteemed societies, including the Association of Gynaecologic Oncologists of India (AGOI), the Indian Society of Colonoscopy and Cervical Pathology (ISCCP), the Royal College of Obstetrics and Gynaecologists (MRCOG), and the Kolkata Gyneoncology Trials and Translational Research Group (KolGO Trg). Moreover, Dr. Chowdhury has published several papers in various national and international journals and has presented topics in many distinguished conferences. His proficiency in the languages of English, Hindi, and Bengali enables him to communicate effectively, empowering patients to share their concerns.
- Expertise in performing Gynaecologic Oncological Surgeries, such as Pelvic and Upper Abdominal Surgeries, Peritonectomies, and Radical Pelvic Floor Clearances in ovarian and cervical cancers, improving the lives of these patients.
- Skilled in Minimally Invasive Laparoscopic Procedures such as Laparoscopic Pelvic and Retroperitoneal Nodal Clearances for the treatment of endometrial cancers.
- Experienced in performing Vulvar Cancer surgeries and providing specialised care for patients.
- English
- Bengali
- Hindi
- Local Mentor for In-Country IGCS Fellowship, India
- LMIC representative for the 1st Endometrial Cancer Consensus Conference for Clinical Research (ECCC-CR) on November 2nd and 3rd, 2023, in Seoul, Korea
- Resource person for training consultants at Chittagong Medical College, Chittagong, Bangladesh [Invited by Medical Education and Health Manpower Development, Directorate General of Medical Education, Dhaka]
- Ghosh DD, Chowdhury R R, Dutta R, Mukhopadhyay I, Mukhopadhyay A, Roychoudhury S. In-silico analysis of TCGA data showing multiple POLE-like favourable subgroups overlapping with TP53 mutated endometrial cancer: Implications for clinical practice in low and middle-income countries. https://doi.org/10.1016/j.gore.2023.101209
- Mandal P, Bhattacharjee B, Sen S, Bhattacharya A, Saha SS, Chowdhury RR, Mondal NR, Chakrabarty B, Chatterjee T, Roy S, Sengupta S. Predominance of genomically defined A lineage of HPV16 over D lineage in Indian patients from eastern India with squamous cell carcinoma of the cervix in association with distinct oncogenic phenotypes. Transl Oncol. 2021 Oct 27;15(1):101256. doi: 10.1016/j.tranon.2021.101256. Epub ahead of print. PMID: 34717279; PMCID: PMC8564679.
- Kurtz JE, Gebski V, Sukhin V, Carey M, Kong I, Glasspool RM, Berek JS, de Paiva Batista M, Hall M, Kim JW, Yeoshoua E, Fujiwara N, Nam BH, Polleis S, Lee JY, Strojna A, Farrelly L, Schwameis R, Fossati R, Darlington AS, Lai CH, Wright AA, Rosenblat O, Harter P, Roxburgh P, Chowdhury RR, Chang TC, Paoletti X, Friedlander M; Gynecologic Cancer InterGroup (GCIG) symptom benefit committee. Incorporating patient centered benefits as endpoints in randomized trials of maintenance therapies in advanced ovarian cancer: A position paper from the GCIG symptom benefit committee. Gynecol Oncol. 2021 May;161(2):502-507. doi: 10.1016/j.ygyno.2021.02.018. Epub 2021 Feb 19. PMID: 33612336.
- Poster presentation
- Mukhopadhyay A, Ghosh T, Bhattacharjee D, Chakraborty D, Gupta , Roychowdhury I, Chatterjee P, Vemekar M, Chowdhury RR, Intermittent PARP Inhibitor Regimen In Ovarian Cancer (IPIROC): Origin and Feasibility Of Implementing A Proof –Of –Concept Exploratory Study.18 October 2023 IGCS Abstracts.
Fellowship & Membership
Overview
Field of Expertise
Languages Spoken
Awards & Achievements
Talks & Publications
- English
- Bengali
- Hindi
Dr. Rahul Roy Chowdhury is a distinguished consultant in the Obstetrics and Gynaecology Department at Manipal Hospitals in Dhakuria, Kolkata, with 33 years of extensive experience, including 19 years as a specialist. He completed his Bachelor of Medicine and Bachelor of Surgery (MBBS) from the esteemed University of Calcutta, India. He then earned a fellowship from the Royal College of Obstetricians and Gynaecologists (FRCOG) in London. Additionally, he holds a Completion Certificate of Training from the Professional Medical Educational and Training Board in the UK. He is the Best Gynecologist Oncologist in Kolkata.
Dr. Chowdhury is widely renowned for his exceptional expertise in performing Pelvic and Upper Abdominal Surgeries, Peritonectomies, and Laparoscopic Procedures tailored specifically for managing endometrial cancers. His specialisation in Gynaecological Oncology occurred at the renowned Oxford Cancer Centre within The John Radcliffe Hospital from 2003 to 2007. Dr. Chowdhury continued to refine his expertise in Gynaecological Oncology across various esteemed institutions. He established himself as a prominent expert in the field upon returning to India in 2008.
Dr. Chowdhury is actively engaged in pioneering clinical research endeavours, contributing significantly to practice-changing trials such as INTERLACE (Induction Chemotherapy in locally advanced cervical cancer). His unwavering dedication to advancing the field of Gynaecological Oncology underscores his commitment to improving patient outcomes and enhancing medical knowledge. Dr. Chowdhury is also associated with esteemed societies, including the Association of Gynaecologic Oncologists of India (AGOI), the Indian Society of Colonoscopy and Cervical Pathology (ISCCP), the Royal College of Obstetrics and Gynaecologists (MRCOG), and the Kolkata Gyneoncology Trials and Translational Research Group (KolGO Trg). Moreover, Dr. Chowdhury has published several papers in various national and international journals and has presented topics in many distinguished conferences. His proficiency in the languages of English, Hindi, and Bengali enables him to communicate effectively, empowering patients to share their concerns.
- Fellow of the Royal College of Obstetricians and Gynaecologists, UK (FRCOG)
- Member of the Royal College of Obstetricians and Gynaecologists, UK (MRCOG)
- Member of the Association of Gynaecologic Oncology
- Member of the Gynae Cancer InterGroup
- Founding member of the Kolkata Gynecological Oncology Trials and Translational Research Group
- Expertise in performing Gynaecologic Oncological Surgeries, such as Pelvic and Upper Abdominal Surgeries, Peritonectomies, and Radical Pelvic Floor Clearances in ovarian and cervical cancers, improving the lives of these patients.
- Skilled in Minimally Invasive Laparoscopic Procedures such as Laparoscopic Pelvic and Retroperitoneal Nodal Clearances for the treatment of endometrial cancers.
- Experienced in performing Vulvar Cancer surgeries and providing specialised care for patients.
- Local Mentor for In-Country IGCS Fellowship, India
- LMIC representative for the 1st Endometrial Cancer Consensus Conference for Clinical Research (ECCC-CR) on November 2nd and 3rd, 2023, in Seoul, Korea
- Resource person for training consultants at Chittagong Medical College, Chittagong, Bangladesh [Invited by Medical Education and Health Manpower Development, Directorate General of Medical Education, Dhaka]
- Ghosh DD, Chowdhury R R, Dutta R, Mukhopadhyay I, Mukhopadhyay A, Roychoudhury S. In-silico analysis of TCGA data showing multiple POLE-like favourable subgroups overlapping with TP53 mutated endometrial cancer: Implications for clinical practice in low and middle-income countries. https://doi.org/10.1016/j.gore.2023.101209
- Mandal P, Bhattacharjee B, Sen S, Bhattacharya A, Saha SS, Chowdhury RR, Mondal NR, Chakrabarty B, Chatterjee T, Roy S, Sengupta S. Predominance of genomically defined A lineage of HPV16 over D lineage in Indian patients from eastern India with squamous cell carcinoma of the cervix in association with distinct oncogenic phenotypes. Transl Oncol. 2021 Oct 27;15(1):101256. doi: 10.1016/j.tranon.2021.101256. Epub ahead of print. PMID: 34717279; PMCID: PMC8564679.
- Kurtz JE, Gebski V, Sukhin V, Carey M, Kong I, Glasspool RM, Berek JS, de Paiva Batista M, Hall M, Kim JW, Yeoshoua E, Fujiwara N, Nam BH, Polleis S, Lee JY, Strojna A, Farrelly L, Schwameis R, Fossati R, Darlington AS, Lai CH, Wright AA, Rosenblat O, Harter P, Roxburgh P, Chowdhury RR, Chang TC, Paoletti X, Friedlander M; Gynecologic Cancer InterGroup (GCIG) symptom benefit committee. Incorporating patient centered benefits as endpoints in randomized trials of maintenance therapies in advanced ovarian cancer: A position paper from the GCIG symptom benefit committee. Gynecol Oncol. 2021 May;161(2):502-507. doi: 10.1016/j.ygyno.2021.02.018. Epub 2021 Feb 19. PMID: 33612336.
- Poster presentation
- Mukhopadhyay A, Ghosh T, Bhattacharjee D, Chakraborty D, Gupta , Roychowdhury I, Chatterjee P, Vemekar M, Chowdhury RR, Intermittent PARP Inhibitor Regimen In Ovarian Cancer (IPIROC): Origin and Feasibility Of Implementing A Proof –Of –Concept Exploratory Study.18 October 2023 IGCS Abstracts.
Languages Spoken
Overview
Fellowship & Membership
Field of Expertise
Awards & Achievements
Talks & Publications
- Expertise in performing Gynaecologic Oncological Surgeries, such as Pelvic and Upper Abdominal Surgeries, Peritonectomies, and Radical Pelvic Floor Clearances in ovarian and cervical cancers, improving the lives of these patients.
- Skilled in Minimally Invasive Laparoscopic Procedures such as Laparoscopic Pelvic and Retroperitoneal Nodal Clearances for the treatment of endometrial cancers.
- Experienced in performing Vulvar Cancer surgeries and providing specialised care for patients.
- Fellow of the Royal College of Obstetricians and Gynaecologists, UK (FRCOG)
- Member of the Royal College of Obstetricians and Gynaecologists, UK (MRCOG)
- Member of the Association of Gynaecologic Oncology
- Member of the Gynae Cancer InterGroup
- Founding member of the Kolkata Gynecological Oncology Trials and Translational Research Group
- English
- Bengali
- Hindi
- Local Mentor for In-Country IGCS Fellowship, India
- LMIC representative for the 1st Endometrial Cancer Consensus Conference for Clinical Research (ECCC-CR) on November 2nd and 3rd, 2023, in Seoul, Korea
- Resource person for training consultants at Chittagong Medical College, Chittagong, Bangladesh [Invited by Medical Education and Health Manpower Development, Directorate General of Medical Education, Dhaka]
- Ghosh DD, Chowdhury R R, Dutta R, Mukhopadhyay I, Mukhopadhyay A, Roychoudhury S. In-silico analysis of TCGA data showing multiple POLE-like favourable subgroups overlapping with TP53 mutated endometrial cancer: Implications for clinical practice in low and middle-income countries. https://doi.org/10.1016/j.gore.2023.101209
- Mandal P, Bhattacharjee B, Sen S, Bhattacharya A, Saha SS, Chowdhury RR, Mondal NR, Chakrabarty B, Chatterjee T, Roy S, Sengupta S. Predominance of genomically defined A lineage of HPV16 over D lineage in Indian patients from eastern India with squamous cell carcinoma of the cervix in association with distinct oncogenic phenotypes. Transl Oncol. 2021 Oct 27;15(1):101256. doi: 10.1016/j.tranon.2021.101256. Epub ahead of print. PMID: 34717279; PMCID: PMC8564679.
- Kurtz JE, Gebski V, Sukhin V, Carey M, Kong I, Glasspool RM, Berek JS, de Paiva Batista M, Hall M, Kim JW, Yeoshoua E, Fujiwara N, Nam BH, Polleis S, Lee JY, Strojna A, Farrelly L, Schwameis R, Fossati R, Darlington AS, Lai CH, Wright AA, Rosenblat O, Harter P, Roxburgh P, Chowdhury RR, Chang TC, Paoletti X, Friedlander M; Gynecologic Cancer InterGroup (GCIG) symptom benefit committee. Incorporating patient centered benefits as endpoints in randomized trials of maintenance therapies in advanced ovarian cancer: A position paper from the GCIG symptom benefit committee. Gynecol Oncol. 2021 May;161(2):502-507. doi: 10.1016/j.ygyno.2021.02.018. Epub 2021 Feb 19. PMID: 33612336.
- Poster presentation
- Mukhopadhyay A, Ghosh T, Bhattacharjee D, Chakraborty D, Gupta , Roychowdhury I, Chatterjee P, Vemekar M, Chowdhury RR, Intermittent PARP Inhibitor Regimen In Ovarian Cancer (IPIROC): Origin and Feasibility Of Implementing A Proof –Of –Concept Exploratory Study.18 October 2023 IGCS Abstracts.
Dr. Rahul Roy Chowdhury is a distinguished consultant in the Obstetrics and Gynaecology Department at Manipal Hospitals in Dhakuria, Kolkata, with 33 years of extensive experience, including 19 years as a specialist. He completed his Bachelor of Medicine and Bachelor of Surgery (MBBS) from the esteemed University of Calcutta, India. He then earned a fellowship from the Royal College of Obstetricians and Gynaecologists (FRCOG) in London. Additionally, he holds a Completion Certificate of Training from the Professional Medical Educational and Training Board in the UK. He is the Best Gynecologist Oncologist in Kolkata.
Dr. Chowdhury is widely renowned for his exceptional expertise in performing Pelvic and Upper Abdominal Surgeries, Peritonectomies, and Laparoscopic Procedures tailored specifically for managing endometrial cancers. His specialisation in Gynaecological Oncology occurred at the renowned Oxford Cancer Centre within The John Radcliffe Hospital from 2003 to 2007. Dr. Chowdhury continued to refine his expertise in Gynaecological Oncology across various esteemed institutions. He established himself as a prominent expert in the field upon returning to India in 2008.
Dr. Chowdhury is actively engaged in pioneering clinical research endeavours, contributing significantly to practice-changing trials such as INTERLACE (Induction Chemotherapy in locally advanced cervical cancer). His unwavering dedication to advancing the field of Gynaecological Oncology underscores his commitment to improving patient outcomes and enhancing medical knowledge. Dr. Chowdhury is also associated with esteemed societies, including the Association of Gynaecologic Oncologists of India (AGOI), the Indian Society of Colonoscopy and Cervical Pathology (ISCCP), the Royal College of Obstetrics and Gynaecologists (MRCOG), and the Kolkata Gyneoncology Trials and Translational Research Group (KolGO Trg). Moreover, Dr. Chowdhury has published several papers in various national and international journals and has presented topics in many distinguished conferences. His proficiency in the languages of English, Hindi, and Bengali enables him to communicate effectively, empowering patients to share their concerns.
Field of Expertise
Fellowship & Membership
Languages Spoken
Awards & Achievements
Talks & Publications
Overview
- Local Mentor for In-Country IGCS Fellowship, India
- LMIC representative for the 1st Endometrial Cancer Consensus Conference for Clinical Research (ECCC-CR) on November 2nd and 3rd, 2023, in Seoul, Korea
- Resource person for training consultants at Chittagong Medical College, Chittagong, Bangladesh [Invited by Medical Education and Health Manpower Development, Directorate General of Medical Education, Dhaka]
- Fellow of the Royal College of Obstetricians and Gynaecologists, UK (FRCOG)
- Member of the Royal College of Obstetricians and Gynaecologists, UK (MRCOG)
- Member of the Association of Gynaecologic Oncology
- Member of the Gynae Cancer InterGroup
- Founding member of the Kolkata Gynecological Oncology Trials and Translational Research Group
- Expertise in performing Gynaecologic Oncological Surgeries, such as Pelvic and Upper Abdominal Surgeries, Peritonectomies, and Radical Pelvic Floor Clearances in ovarian and cervical cancers, improving the lives of these patients.
- Skilled in Minimally Invasive Laparoscopic Procedures such as Laparoscopic Pelvic and Retroperitoneal Nodal Clearances for the treatment of endometrial cancers.
- Experienced in performing Vulvar Cancer surgeries and providing specialised care for patients.
- English
- Bengali
- Hindi
- Ghosh DD, Chowdhury R R, Dutta R, Mukhopadhyay I, Mukhopadhyay A, Roychoudhury S. In-silico analysis of TCGA data showing multiple POLE-like favourable subgroups overlapping with TP53 mutated endometrial cancer: Implications for clinical practice in low and middle-income countries. https://doi.org/10.1016/j.gore.2023.101209
- Mandal P, Bhattacharjee B, Sen S, Bhattacharya A, Saha SS, Chowdhury RR, Mondal NR, Chakrabarty B, Chatterjee T, Roy S, Sengupta S. Predominance of genomically defined A lineage of HPV16 over D lineage in Indian patients from eastern India with squamous cell carcinoma of the cervix in association with distinct oncogenic phenotypes. Transl Oncol. 2021 Oct 27;15(1):101256. doi: 10.1016/j.tranon.2021.101256. Epub ahead of print. PMID: 34717279; PMCID: PMC8564679.
- Kurtz JE, Gebski V, Sukhin V, Carey M, Kong I, Glasspool RM, Berek JS, de Paiva Batista M, Hall M, Kim JW, Yeoshoua E, Fujiwara N, Nam BH, Polleis S, Lee JY, Strojna A, Farrelly L, Schwameis R, Fossati R, Darlington AS, Lai CH, Wright AA, Rosenblat O, Harter P, Roxburgh P, Chowdhury RR, Chang TC, Paoletti X, Friedlander M; Gynecologic Cancer InterGroup (GCIG) symptom benefit committee. Incorporating patient centered benefits as endpoints in randomized trials of maintenance therapies in advanced ovarian cancer: A position paper from the GCIG symptom benefit committee. Gynecol Oncol. 2021 May;161(2):502-507. doi: 10.1016/j.ygyno.2021.02.018. Epub 2021 Feb 19. PMID: 33612336.
- Poster presentation
- Mukhopadhyay A, Ghosh T, Bhattacharjee D, Chakraborty D, Gupta , Roychowdhury I, Chatterjee P, Vemekar M, Chowdhury RR, Intermittent PARP Inhibitor Regimen In Ovarian Cancer (IPIROC): Origin and Feasibility Of Implementing A Proof –Of –Concept Exploratory Study.18 October 2023 IGCS Abstracts.
Dr. Rahul Roy Chowdhury is a distinguished consultant in the Obstetrics and Gynaecology Department at Manipal Hospitals in Dhakuria, Kolkata, with 33 years of extensive experience, including 19 years as a specialist. He completed his Bachelor of Medicine and Bachelor of Surgery (MBBS) from the esteemed University of Calcutta, India. He then earned a fellowship from the Royal College of Obstetricians and Gynaecologists (FRCOG) in London. Additionally, he holds a Completion Certificate of Training from the Professional Medical Educational and Training Board in the UK. He is the Best Gynecologist Oncologist in Kolkata.
Dr. Chowdhury is widely renowned for his exceptional expertise in performing Pelvic and Upper Abdominal Surgeries, Peritonectomies, and Laparoscopic Procedures tailored specifically for managing endometrial cancers. His specialisation in Gynaecological Oncology occurred at the renowned Oxford Cancer Centre within The John Radcliffe Hospital from 2003 to 2007. Dr. Chowdhury continued to refine his expertise in Gynaecological Oncology across various esteemed institutions. He established himself as a prominent expert in the field upon returning to India in 2008.
Dr. Chowdhury is actively engaged in pioneering clinical research endeavours, contributing significantly to practice-changing trials such as INTERLACE (Induction Chemotherapy in locally advanced cervical cancer). His unwavering dedication to advancing the field of Gynaecological Oncology underscores his commitment to improving patient outcomes and enhancing medical knowledge. Dr. Chowdhury is also associated with esteemed societies, including the Association of Gynaecologic Oncologists of India (AGOI), the Indian Society of Colonoscopy and Cervical Pathology (ISCCP), the Royal College of Obstetrics and Gynaecologists (MRCOG), and the Kolkata Gyneoncology Trials and Translational Research Group (KolGO Trg). Moreover, Dr. Chowdhury has published several papers in various national and international journals and has presented topics in many distinguished conferences. His proficiency in the languages of English, Hindi, and Bengali enables him to communicate effectively, empowering patients to share their concerns.
Awards & Achievements
Fellowship & Membership
Field of Expertise
Languages Spoken
Talks & Publications
Overview
- Ghosh DD, Chowdhury R R, Dutta R, Mukhopadhyay I, Mukhopadhyay A, Roychoudhury S. In-silico analysis of TCGA data showing multiple POLE-like favourable subgroups overlapping with TP53 mutated endometrial cancer: Implications for clinical practice in low and middle-income countries. https://doi.org/10.1016/j.gore.2023.101209
- Mandal P, Bhattacharjee B, Sen S, Bhattacharya A, Saha SS, Chowdhury RR, Mondal NR, Chakrabarty B, Chatterjee T, Roy S, Sengupta S. Predominance of genomically defined A lineage of HPV16 over D lineage in Indian patients from eastern India with squamous cell carcinoma of the cervix in association with distinct oncogenic phenotypes. Transl Oncol. 2021 Oct 27;15(1):101256. doi: 10.1016/j.tranon.2021.101256. Epub ahead of print. PMID: 34717279; PMCID: PMC8564679.
- Kurtz JE, Gebski V, Sukhin V, Carey M, Kong I, Glasspool RM, Berek JS, de Paiva Batista M, Hall M, Kim JW, Yeoshoua E, Fujiwara N, Nam BH, Polleis S, Lee JY, Strojna A, Farrelly L, Schwameis R, Fossati R, Darlington AS, Lai CH, Wright AA, Rosenblat O, Harter P, Roxburgh P, Chowdhury RR, Chang TC, Paoletti X, Friedlander M; Gynecologic Cancer InterGroup (GCIG) symptom benefit committee. Incorporating patient centered benefits as endpoints in randomized trials of maintenance therapies in advanced ovarian cancer: A position paper from the GCIG symptom benefit committee. Gynecol Oncol. 2021 May;161(2):502-507. doi: 10.1016/j.ygyno.2021.02.018. Epub 2021 Feb 19. PMID: 33612336.
- Poster presentation
- Mukhopadhyay A, Ghosh T, Bhattacharjee D, Chakraborty D, Gupta , Roychowdhury I, Chatterjee P, Vemekar M, Chowdhury RR, Intermittent PARP Inhibitor Regimen In Ovarian Cancer (IPIROC): Origin and Feasibility Of Implementing A Proof –Of –Concept Exploratory Study.18 October 2023 IGCS Abstracts.
Dr. Rahul Roy Chowdhury is a distinguished consultant in the Obstetrics and Gynaecology Department at Manipal Hospitals in Dhakuria, Kolkata, with 33 years of extensive experience, including 19 years as a specialist. He completed his Bachelor of Medicine and Bachelor of Surgery (MBBS) from the esteemed University of Calcutta, India. He then earned a fellowship from the Royal College of Obstetricians and Gynaecologists (FRCOG) in London. Additionally, he holds a Completion Certificate of Training from the Professional Medical Educational and Training Board in the UK. He is the Best Gynecologist Oncologist in Kolkata.
Dr. Chowdhury is widely renowned for his exceptional expertise in performing Pelvic and Upper Abdominal Surgeries, Peritonectomies, and Laparoscopic Procedures tailored specifically for managing endometrial cancers. His specialisation in Gynaecological Oncology occurred at the renowned Oxford Cancer Centre within The John Radcliffe Hospital from 2003 to 2007. Dr. Chowdhury continued to refine his expertise in Gynaecological Oncology across various esteemed institutions. He established himself as a prominent expert in the field upon returning to India in 2008.
Dr. Chowdhury is actively engaged in pioneering clinical research endeavours, contributing significantly to practice-changing trials such as INTERLACE (Induction Chemotherapy in locally advanced cervical cancer). His unwavering dedication to advancing the field of Gynaecological Oncology underscores his commitment to improving patient outcomes and enhancing medical knowledge. Dr. Chowdhury is also associated with esteemed societies, including the Association of Gynaecologic Oncologists of India (AGOI), the Indian Society of Colonoscopy and Cervical Pathology (ISCCP), the Royal College of Obstetrics and Gynaecologists (MRCOG), and the Kolkata Gyneoncology Trials and Translational Research Group (KolGO Trg). Moreover, Dr. Chowdhury has published several papers in various national and international journals and has presented topics in many distinguished conferences. His proficiency in the languages of English, Hindi, and Bengali enables him to communicate effectively, empowering patients to share their concerns.
- Fellow of the Royal College of Obstetricians and Gynaecologists, UK (FRCOG)
- Member of the Royal College of Obstetricians and Gynaecologists, UK (MRCOG)
- Member of the Association of Gynaecologic Oncology
- Member of the Gynae Cancer InterGroup
- Founding member of the Kolkata Gynecological Oncology Trials and Translational Research Group
- Expertise in performing Gynaecologic Oncological Surgeries, such as Pelvic and Upper Abdominal Surgeries, Peritonectomies, and Radical Pelvic Floor Clearances in ovarian and cervical cancers, improving the lives of these patients.
- Skilled in Minimally Invasive Laparoscopic Procedures such as Laparoscopic Pelvic and Retroperitoneal Nodal Clearances for the treatment of endometrial cancers.
- Experienced in performing Vulvar Cancer surgeries and providing specialised care for patients.
- English
- Bengali
- Hindi
- Local Mentor for In-Country IGCS Fellowship, India
- LMIC representative for the 1st Endometrial Cancer Consensus Conference for Clinical Research (ECCC-CR) on November 2nd and 3rd, 2023, in Seoul, Korea
- Resource person for training consultants at Chittagong Medical College, Chittagong, Bangladesh [Invited by Medical Education and Health Manpower Development, Directorate General of Medical Education, Dhaka]
Talks & Publications
Overview
Fellowship & Membership
Field of Expertise
Languages Spoken
Awards & Achievements
FAQ's
Patients visit Dr. Rahul Roy Chowdhury, a leading Consultant - Gynaecological Oncology Specialist at Manipal Hospitals Dhakuria, for expert care and advanced treatments. Known for accurate diagnoses and patient centric care, Dr. Rahul Roy Chowdhury is a trusted choice for exceptional medical support.
Dr. Rahul Roy Chowdhury Specialises in:
- Expertise in performing Gynaecologic Oncological Surgeries, such as Pelvic and Upper Abdominal Surgeries, Peritonectomies, and Radical Pelvic Floor Clearances in ovarian and cervical cancers, improving the lives of these patients.
- Skilled in Minimally Invasive Laparoscopic Procedures such as Laparoscopic Pelvic and Retroperitoneal Nodal Clearances for the treatment of endometrial cancers.
- Experienced in performing Vulvar Cancer surgeries and providing specialised care for patients.
To book an appointment with Dr. Rahul Roy Chowdhury at Manipal Hospitals Dhakuria, please call 033 6907 0001. Our dedicated team will assist you in scheduling a convenient time for your consultation.
Dr. Rahul Roy Chowdhury has extensive experience and qualifications in Obstetrics and Gynaecology, Gynaec Oncology at Manipal Hospitals Dhakuria. With expertise spanning MBBS | MRCOG (London) | FRCOG (UK), bringing a wealth of knowledge and skill to their practice, ensuring top-notch patient care. Dr. Rahul Roy Chowdhury has also published numerous articles and publications in the field of Obstetrics and Gynaecology, Gynaec Oncology.
For your initial appointment with Dr. Rahul Roy Chowdhury, please bring any relevant medical records, including previous imaging scans, laboratory results, and medication lists. It's important to provide a detailed medical history and any pertinent information about your condition. If you have insurance, please bring your insurance card and any necessary referral documents. This will help facilitate a comprehensive evaluation and discussion during your appointment.
Refund Policy
1) Up to 4 hrs of appointment time:
Rescheduling of doctor appointment can be done within a week from the date of appointment as per doctor / slot availability.
Cancellation can be done with full refund of the payment.
2) Up to 2 hrs of appointment time:
Rescheduling of doctor appointment can be done within a week from the date of appointment as per doctor / slot availability.
Cancellation of appointment and refund with a cancellation charge of Rs.100/-.
3) Less than 2 hrs of appointment time:
Rescheduling / cancellation of appointment cannot be done, payment non-refundable in this case. However, Units can have the discretion to refund / reschedule in case of exigencies.
Please note : While making the payment online, above mentioned payment terms and conditions should be agreed upon by customers, by clicking in a box ( I agree) and then proceed for payment.
PATIENT CONSENT FOR TELEMEDICINE / TELECONSULTATION
Telemedicine involves the use of electronic communications to enable Hospitals/health care centres to provide healthcare services at different locations through exchange of information and for the purpose of improving patient care. I, confirm that I have received the necessary information to sign this form and I agree to take part in a live telemedicine/teleconsultation session with Manipal Hospitals.
I understand that:
- Interactive audio/video connection, electronic information and communication technologies shall be used for providing me with a telemedicine/teleconsultation.
- In case the information obtained via teleconsultation is not sufficient to make a diagnosis, I may be required to go to Manipal Hospitals for in-person consultation.
- Though the telemedicine/teleconsultation is private, other individuals, medical and non-medical, may be present to facilitate the consultation and that they will take reasonable steps to maintain confidentiality of the information obtained.
- A limited visual examination will take place during the telemedicine/teleconsultation and that it cannot replace a full medical examination done physically at Manipal Hospitals.
- I have the right to withhold or withdraw my consent to the use of telemedicine/teleconsultation in the course of my care at any time, without affecting my right to future care or treatment. I may also revoke my consent orally or in writing at any time.
- I may be prescribed medicines for treatment or/and diagnostic tests to further evaluate my health condition. All prescription will be sent to my registered email/phone no. Manipal Hospitals will keep a record of the consultation & prescription in my medical record.
- The telemedicine/teleconsultation services are not in any way intended to be used in case of an emergency.
- There can be potential risks with this technology e.g information transmitted may not be sufficient to allow for appropriate medical decision, the video /audio may disconnect/stop in-between, security protocols could fail causing a breach of privacy of personal medical information.
- Any relevant medical information about me including details of my medical history, examinations, x-rays, tests, photographs or other images may be transmitted /shared by Manipal Hospitals with their staff, specialist, business partners for the purpose of record, communications, feedback, enquires, follow ups, analysis etc.
- Manipal Hospitals responsibility shall terminate upon conclusion of this teleconference.
- I hereby consent that in consideration for the telemedicine / teleconsultation services rendered to me, I agree to pay the relevant charges.
- I hereby release Manipal Hospitals, its personnel and any other person participating in my care from any and all liability which may arise from authorized use of such Video / E-Consultation, Videotapes, Digital recording films and Photographs. I have read this document and understand the risk of the telemedicine / teleconsultation.
- I hereby consent to participate in a telemedicine / teleconsultation under the terms & conditions described in this document.
